Branded Generics Market 2027 By Therapeutic Application, Distribution Channel, Drug Class, Formulation Type | The Insight Partners

Branded Generics Market to 2027 - Global Analysis and Forecasts by Therapeutic Application (Oncology, Cardiovascular Diseases, Diabetes, Neurology, Gastrointestinal Diseases, Dermatology Diseases, Analgesics And Anti-Inflammatory); Distribution Channel (Hospitals pharmacies, Retail pharmacies. Online pharmacies, Drug stores); Drug Class (Alkylating Agents, Antimetabolites, Hormones, Anti-Hypertensive, Lipid Lowering Drugs, Anti-Depressants, Anti-Psychotics, Anti-Epileptic, Others); Formulation Type (Oral, Parental, Topical, Others)

Report Code: TIPRE00005554 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Branded Generics are a patented drug, a novel dosage form of a generic drug with a definite trade name. The manufactures opt for this to gain profit from their customers who realize their medication has come off patent and that there are cheaper generics available.

MARKET DYNAMICS
The Branded Generics market is anticipated to grow in the forecast, owing to the factors such as increasing off patent pharmaceutical companies, entry of new market players, changing medicine practices and rising awareness of the patients.

MARKET SCOPE
The "Global Branded Generics Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Branded Generics market with detailed market segmentation by therapeutic application, distribution channel, drug class, formulation type and geography. The global Branded Generics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Branded Generics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Branded Generics market is segmented on the basis of therapeutic application, distribution channel, drug class and formulation type. Based on therapeutic application the market is segmented into oncology, cardiovascular diseases, diabetes, neurology, gastrointestinal diseases, dermatology diseases, analgesics and anti-inflammatory. Based on distribution channel the market is segmented into Hospitals pharmacies, Retail pharmacies. Online pharmacies, Drug stores. Based on drug class the market is segmented into Alkylating Agents, Antimetabolites, Hormones, Anti-Hypertensive, Lipid Lowering Drugs, Anti-Depressants, Anti-Psychotics, Anti-Epileptic, Others. Based on Formulation type the market is segmented into Oral, Parental, Topical, Others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Branded Generics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Branded Generics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Branded Generics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Branded Generics market in these regions.

MARKET PLAYERS
The reports cover key developments in the Branded Generics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Branded Generics market are anticipated to lucrative growth opportunities in the future with the rising demand for Branded Generics market in the global market. Below mentioned is the list of few companies engaged in the Branded Generics market.

The report also includes the profiles of Branded Generics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Mylan N.V
  • Teva Pharmaceutical Industries Ltd
  • GlaxoSmithKline plc
  • Bausch Health (Valeant Pharmaceuticals)
  • Sandoz International GmbH
  • Zydus Cadila
  • Par Pharmaceutical
  • Lupin Pharmaceuticals, Inc
  • Sanofi
  • AstraZeneca
  • Dr. Reddy's Laboratories Ltd
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Branded Generics Market - By Therapeutic Application
1.3.2 Branded Generics Market - By Distribution Channel
1.3.3 Branded Generics Market - By Drug Class
1.3.4 Branded Generics Market - By Formulation Type
1.3.5 Branded Generics Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BRANDED GENERICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BRANDED GENERICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BRANDED GENERICS MARKET - GLOBAL MARKET ANALYSIS
6.1. BRANDED GENERICS - GLOBAL MARKET OVERVIEW
6.2. BRANDED GENERICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. BRANDED GENERICS MARKET - REVENUE AND FORECASTS TO 2027 - THERAPEUTIC APPLICATION
7.1. OVERVIEW
7.2. THERAPEUTIC APPLICATION MARKET FORECASTS AND ANALYSIS
7.3. ONCOLOGY
7.3.1. Overview
7.3.2. Oncology Market Forecast and Analysis
7.4. CARDIOVASCULAR DISEASES
7.4.1. Overview
7.4.2. Cardiovascular Diseases Market Forecast and Analysis
7.5. DIABETES
7.5.1. Overview
7.5.2. Diabetes Market Forecast and Analysis
7.6. NEUROLOGY
7.6.1. Overview
7.6.2. Neurology Market Forecast and Analysis
7.7. GASTROINTESTINAL DISEASES
7.7.1. Overview
7.7.2. Gastrointestinal Diseases Market Forecast and Analysis
7.8. DERMATOLOGY DISEASES
7.8.1. Overview
7.8.2. Dermatology Diseases Market Forecast and Analysis
7.9. ANALGESICS AND ANTI-INFLAMMATORY
7.9.1. Overview
7.9.2. Analgesics And Anti-Inflammatory Market Forecast and Analysis
8. BRANDED GENERICS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS PHARMACIES
8.3.1. Overview
8.3.2. Hospitals pharmacies Market Forecast and Analysis
8.4. RETAIL PHARMACIES. ONLINE PHARMACIES
8.4.1. Overview
8.4.2. Retail pharmacies. Online pharmacies Market Forecast and Analysis
8.5. DRUG STORES
8.5.1. Overview
8.5.2. Drug stores Market Forecast and Analysis
9. BRANDED GENERICS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG CLASS
9.1. OVERVIEW
9.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
9.3. ALKYLATING AGENTS
9.3.1. Overview
9.3.2. Alkylating Agents Market Forecast and Analysis
9.4. ANTIMETABOLITES
9.4.1. Overview
9.4.2. Antimetabolites Market Forecast and Analysis
9.5. HORMONES
9.5.1. Overview
9.5.2. Hormones Market Forecast and Analysis
9.6. ANTI-HYPERTENSIVE
9.6.1. Overview
9.6.2. Anti-Hypertensive Market Forecast and Analysis
9.7. LIPID LOWERING DRUGS
9.7.1. Overview
9.7.2. Lipid Lowering Drugs Market Forecast and Analysis
9.8. ANTI-DEPRESSANTS
9.8.1. Overview
9.8.2. Anti-Depressants Market Forecast and Analysis
9.9. ANTI-PSYCHOTICS
9.9.1. Overview
9.9.2. Anti-Psychotics Market Forecast and Analysis
9.10. ANTI-EPILEPTIC
9.10.1. Overview
9.10.2. Anti-Epileptic Market Forecast and Analysis
9.11. OTHERS
9.11.1. Overview
9.11.2. Others Market Forecast and Analysis
10. BRANDED GENERICS MARKET - REVENUE AND FORECASTS TO 2027 - FORMULATION TYPE
10.1. OVERVIEW
10.2. FORMULATION TYPE MARKET FORECASTS AND ANALYSIS
10.3. ORAL
10.3.1. Overview
10.3.2. Oral Market Forecast and Analysis
10.4. PARENTAL
10.4.1. Overview
10.4.2. Parental Market Forecast and Analysis
10.5. TOPICAL
10.5.1. Overview
10.5.2. Topical Market Forecast and Analysis
10.6. OTHERS.
10.6.1. Overview
10.6.2. Others. Market Forecast and Analysis
11. BRANDED GENERICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Branded Generics Market Overview
11.1.2 North America Branded Generics Market Forecasts and Analysis
11.1.3 North America Branded Generics Market Forecasts and Analysis - By Therapeutic Application
11.1.4 North America Branded Generics Market Forecasts and Analysis - By Distribution Channel
11.1.5 North America Branded Generics Market Forecasts and Analysis - By Drug Class
11.1.6 North America Branded Generics Market Forecasts and Analysis - By Formulation Type
11.1.7 North America Branded Generics Market Forecasts and Analysis - By Countries
11.1.7.1 United States Branded Generics Market
11.1.7.1.1 United States Branded Generics Market by Therapeutic Application
11.1.7.1.2 United States Branded Generics Market by Distribution Channel
11.1.7.1.3 United States Branded Generics Market by Drug Class
11.1.7.1.4 United States Branded Generics Market by Formulation Type
11.1.7.2 Canada Branded Generics Market
11.1.7.2.1 Canada Branded Generics Market by Therapeutic Application
11.1.7.2.2 Canada Branded Generics Market by Distribution Channel
11.1.7.2.3 Canada Branded Generics Market by Drug Class
11.1.7.2.4 Canada Branded Generics Market by Formulation Type
11.1.7.3 Mexico Branded Generics Market
11.1.7.3.1 Mexico Branded Generics Market by Therapeutic Application
11.1.7.3.2 Mexico Branded Generics Market by Distribution Channel
11.1.7.3.3 Mexico Branded Generics Market by Drug Class
11.1.7.3.4 Mexico Branded Generics Market by Formulation Type
11.2. EUROPE
11.2.1 Europe Branded Generics Market Overview
11.2.2 Europe Branded Generics Market Forecasts and Analysis
11.2.3 Europe Branded Generics Market Forecasts and Analysis - By Therapeutic Application
11.2.4 Europe Branded Generics Market Forecasts and Analysis - By Distribution Channel
11.2.5 Europe Branded Generics Market Forecasts and Analysis - By Drug Class
11.2.6 Europe Branded Generics Market Forecasts and Analysis - By Formulation Type
11.2.7 Europe Branded Generics Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Branded Generics Market
11.2.7.1.1 Germany Branded Generics Market by Therapeutic Application
11.2.7.1.2 Germany Branded Generics Market by Distribution Channel
11.2.7.1.3 Germany Branded Generics Market by Drug Class
11.2.7.1.4 Germany Branded Generics Market by Formulation Type
11.2.7.2 France Branded Generics Market
11.2.7.2.1 France Branded Generics Market by Therapeutic Application
11.2.7.2.2 France Branded Generics Market by Distribution Channel
11.2.7.2.3 France Branded Generics Market by Drug Class
11.2.7.2.4 France Branded Generics Market by Formulation Type
11.2.7.3 Italy Branded Generics Market
11.2.7.3.1 Italy Branded Generics Market by Therapeutic Application
11.2.7.3.2 Italy Branded Generics Market by Distribution Channel
11.2.7.3.3 Italy Branded Generics Market by Drug Class
11.2.7.3.4 Italy Branded Generics Market by Formulation Type
11.2.7.4 Spain Branded Generics Market
11.2.7.4.1 Spain Branded Generics Market by Therapeutic Application
11.2.7.4.2 Spain Branded Generics Market by Distribution Channel
11.2.7.4.3 Spain Branded Generics Market by Drug Class
11.2.7.4.4 Spain Branded Generics Market by Formulation Type
11.2.7.5 United Kingdom Branded Generics Market
11.2.7.5.1 United Kingdom Branded Generics Market by Therapeutic Application
11.2.7.5.2 United Kingdom Branded Generics Market by Distribution Channel
11.2.7.5.3 United Kingdom Branded Generics Market by Drug Class
11.2.7.5.4 United Kingdom Branded Generics Market by Formulation Type
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Branded Generics Market Overview
11.3.2 Asia-Pacific Branded Generics Market Forecasts and Analysis
11.3.3 Asia-Pacific Branded Generics Market Forecasts and Analysis - By Therapeutic Application
11.3.4 Asia-Pacific Branded Generics Market Forecasts and Analysis - By Distribution Channel
11.3.5 Asia-Pacific Branded Generics Market Forecasts and Analysis - By Drug Class
11.3.6 Asia-Pacific Branded Generics Market Forecasts and Analysis - By Formulation Type
11.3.7 Asia-Pacific Branded Generics Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Branded Generics Market
11.3.7.1.1 Australia Branded Generics Market by Therapeutic Application
11.3.7.1.2 Australia Branded Generics Market by Distribution Channel
11.3.7.1.3 Australia Branded Generics Market by Drug Class
11.3.7.1.4 Australia Branded Generics Market by Formulation Type
11.3.7.2 China Branded Generics Market
11.3.7.2.1 China Branded Generics Market by Therapeutic Application
11.3.7.2.2 China Branded Generics Market by Distribution Channel
11.3.7.2.3 China Branded Generics Market by Drug Class
11.3.7.2.4 China Branded Generics Market by Formulation Type
11.3.7.3 India Branded Generics Market
11.3.7.3.1 India Branded Generics Market by Therapeutic Application
11.3.7.3.2 India Branded Generics Market by Distribution Channel
11.3.7.3.3 India Branded Generics Market by Drug Class
11.3.7.3.4 India Branded Generics Market by Formulation Type
11.3.7.4 Japan Branded Generics Market
11.3.7.4.1 Japan Branded Generics Market by Therapeutic Application
11.3.7.4.2 Japan Branded Generics Market by Distribution Channel
11.3.7.4.3 Japan Branded Generics Market by Drug Class
11.3.7.4.4 Japan Branded Generics Market by Formulation Type
11.3.7.5 South Korea Branded Generics Market
11.3.7.5.1 South Korea Branded Generics Market by Therapeutic Application
11.3.7.5.2 South Korea Branded Generics Market by Distribution Channel
11.3.7.5.3 South Korea Branded Generics Market by Drug Class
11.3.7.5.4 South Korea Branded Generics Market by Formulation Type
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Branded Generics Market Overview
11.4.2 Middle East and Africa Branded Generics Market Forecasts and Analysis
11.4.3 Middle East and Africa Branded Generics Market Forecasts and Analysis - By Therapeutic Application
11.4.4 Middle East and Africa Branded Generics Market Forecasts and Analysis - By Distribution Channel
11.4.5 Middle East and Africa Branded Generics Market Forecasts and Analysis - By Drug Class
11.4.6 Middle East and Africa Branded Generics Market Forecasts and Analysis - By Formulation Type
11.4.7 Middle East and Africa Branded Generics Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Branded Generics Market
11.4.7.1.1 South Africa Branded Generics Market by Therapeutic Application
11.4.7.1.2 South Africa Branded Generics Market by Distribution Channel
11.4.7.1.3 South Africa Branded Generics Market by Drug Class
11.4.7.1.4 South Africa Branded Generics Market by Formulation Type
11.4.7.2 Saudi Arabia Branded Generics Market
11.4.7.2.1 Saudi Arabia Branded Generics Market by Therapeutic Application
11.4.7.2.2 Saudi Arabia Branded Generics Market by Distribution Channel
11.4.7.2.3 Saudi Arabia Branded Generics Market by Drug Class
11.4.7.2.4 Saudi Arabia Branded Generics Market by Formulation Type
11.4.7.3 U.A.E Branded Generics Market
11.4.7.3.1 U.A.E Branded Generics Market by Therapeutic Application
11.4.7.3.2 U.A.E Branded Generics Market by Distribution Channel
11.4.7.3.3 U.A.E Branded Generics Market by Drug Class
11.4.7.3.4 U.A.E Branded Generics Market by Formulation Type
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Branded Generics Market Overview
11.5.2 South and Central America Branded Generics Market Forecasts and Analysis
11.5.3 South and Central America Branded Generics Market Forecasts and Analysis - By Therapeutic Application
11.5.4 South and Central America Branded Generics Market Forecasts and Analysis - By Distribution Channel
11.5.5 South and Central America Branded Generics Market Forecasts and Analysis - By Drug Class
11.5.6 South and Central America Branded Generics Market Forecasts and Analysis - By Formulation Type
11.5.7 South and Central America Branded Generics Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Branded Generics Market
11.5.7.1.1 Brazil Branded Generics Market by Therapeutic Application
11.5.7.1.2 Brazil Branded Generics Market by Distribution Channel
11.5.7.1.3 Brazil Branded Generics Market by Drug Class
11.5.7.1.4 Brazil Branded Generics Market by Formulation Type
11.5.7.2 Argentina Branded Generics Market
11.5.7.2.1 Argentina Branded Generics Market by Therapeutic Application
11.5.7.2.2 Argentina Branded Generics Market by Distribution Channel
11.5.7.2.3 Argentina Branded Generics Market by Drug Class
11.5.7.2.4 Argentina Branded Generics Market by Formulation Type
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. BRANDED GENERICS MARKET, KEY COMPANY PROFILES
13.1. MYLAN N.V
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. TEVA PHARMACEUTICAL INDUSTRIES LTD
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. GLAXOSMITHKLINE PLC
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. BAUSCH HEALTH (VALEANT PHARMACEUTICALS)
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. SANDOZ INTERNATIONAL GMBH
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. ZYDUS CADILA
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. PAR PHARMACEUTICAL
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. LUPIN PHARMACEUTICALS, INC
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. SANOFI
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. ASTRAZENECA
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
13.11. DR. REDDY’S LABORATORIES LTD
13.11.1. Key Facts
13.11.2. Business Description
13.11.3. Products and Services
13.11.4. Financial Overview
13.11.5. SWOT Analysis
13.11.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

- Mylan N.V
- Teva Pharmaceutical Industries Ltd
- GlaxoSmithKline plc
- Bausch Health (Valeant Pharmaceuticals)
- Sandoz International GmbH
- Zydus Cadila
- Par Pharmaceutical
- Lupin Pharmaceuticals, Inc
- Sanofi
- AstraZeneca
- Dr. Reddy's Laboratories Ltd